Dual Inhibition of PI3K and mTOR as an Alternative Treatment for Kaposi's Sarcoma

Cancer Research - United States
doi 10.1158/0008-5472.can-08-0878
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Dual PI3K/mTOR Inhibition in Colorectal Cancers withAPCandPIK3CAMutations

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2016English

Honokiol-Mediated Inhibition of PI3K/mTOR Pathway

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2009English

Everolimus for Kaposi's Sarcoma Treatment After Kidney Transplantation

Vestnik Transplantologii i Iskusstvennykh Organov
AllergyImmunologyTransplantation
2015English

Design, Synthesis and Biological Evaluation of Novel Phenylsulfonylurea Derivatives as PI3K/mTOR Dual Inhibitors

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2018English

Dual Inhibition of PI3K and mTOR Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2013English

In Vitro Effects of PI3K/mTOR Inhibition in Canine Hemangiosarcoma

PLoS ONE
Multidisciplinary
2018English

AXL Circumvents PI3K Inhibition by Activating EGFR-PKC-mTOR Signaling

Cancer Discovery
Oncology
2015English

Dual Inhibition of ULK1 and mTOR Enhances Tumor Cell Apoptosis

Cancer Discovery
Oncology
2015English

Kaposi's Sarcoma-Associated Herpesvirus

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy